• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Relationship between the dynamic changes of serum 2019-nCoV IgM/IgG and patient immunity after 6 month hospital discharge.血清 2019-nCoV IgM/IgG 动态变化与患者出院后 6 个月内免疫力的关系。
Inflamm Res. 2021 Feb;70(2):241-247. doi: 10.1007/s00011-020-01429-8. Epub 2021 Jan 1.
2
Immune cell profiling and antibody responses in patients with COVID-19.新型冠状病毒肺炎患者的免疫细胞谱和抗体反应。
BMC Infect Dis. 2021 Jul 5;21(1):646. doi: 10.1186/s12879-021-06278-2.
3
Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.COVID-19 患者在疫情早期对 SARS-CoV-2 抗体的动态变化。
Virol Sin. 2020 Dec;35(6):744-751. doi: 10.1007/s12250-020-00268-5. Epub 2020 Jul 27.
4
Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.SARS-CoV-2 感染和 COVID-19 康复过程中抗 SARS-CoV-2 抗体的动态变化。
Nat Commun. 2020 Nov 27;11(1):6044. doi: 10.1038/s41467-020-19943-y.
5
Decline of SARS-CoV-2-specific IgG, IgM and IgA in convalescent COVID-19 patients within 100 days after hospital discharge.康复期新冠患者出院后100天内SARS-CoV-2特异性IgG、IgM和IgA水平下降
Sci China Life Sci. 2021 Mar;64(3):482-485. doi: 10.1007/s11427-020-1805-0. Epub 2020 Aug 28.
6
Evaluation of the Levels of Peripheral CD3, CD4, and CD8 T Cells and IgG and IgM Antibodies in COVID-19 Patients at Different Stages of Infection.评价不同感染阶段 COVID-19 患者外周血 CD3、CD4、CD8 T 细胞及 IgG、IgM 抗体水平。
Microbiol Spectr. 2022 Feb 23;10(1):e0084521. doi: 10.1128/spectrum.00845-21.
7
The dynamic changes of serum IgM and IgG against SARS-CoV-2 in patients with COVID-19.新型冠状病毒肺炎患者血清 IgM 和 IgG 对 SARS-CoV-2 的动态变化。
J Med Virol. 2021 Feb;93(2):924-933. doi: 10.1002/jmv.26353. Epub 2020 Sep 28.
8
Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19.重症和危重症新型冠状病毒肺炎患者淋巴细胞亚群及相关细胞因子水平的动态变化
BMC Infect Dis. 2021 Jan 18;21(1):79. doi: 10.1186/s12879-021-05792-7.
9
Highlighted Prospects of an IgM/IgG Antibodies Test in Identifying Individuals With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.IgM/IgG 抗体检测在识别无症状严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染个体方面的显著前景。
Arch Pathol Lab Med. 2021 Jan 1;145(1):39-45. doi: 10.5858/arpa.2020-0310-SA.
10
[Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].[意大利北部皮埃蒙特大区博尔戈塞西亚人群中抗SARS-CoV-2 IgG/IgM抗体的血清流行率:封锁后时期的监测策略?]
Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):200-206. doi: 10.19191/EP20.5-6.S2.119.

引用本文的文献

1
A multimodality score strategy for assessing the risk of immune checkpoint inhibitors related cardiotoxicity.一种用于评估免疫检查点抑制剂相关心脏毒性风险的多模态评分策略。
Sci Rep. 2024 Oct 22;14(1):24821. doi: 10.1038/s41598-024-76829-5.
2
Measurement of antibody levels in patients with COVID-19 over time by immunofluorescence assay: a longitudinal observational study.通过免疫荧光测定法测定 COVID-19 患者随时间推移的抗体水平:一项纵向观察研究。
J Int Med Res. 2022 Jan;50(1):3000605211069279. doi: 10.1177/03000605211069279.

本文引用的文献

1
East-West differences in clinical manifestations of COVID-19 patients: A systematic literature review and meta-analysis.东西方 COVID-19 患者临床表现的差异:系统文献回顾和荟萃分析。
J Med Virol. 2021 May;93(5):2683-2693. doi: 10.1002/jmv.26737. Epub 2021 Feb 23.
2
Structural Basis for Designing Multiepitope Vaccines Against COVID-19 Infection: In Silico Vaccine Design and Validation.针对新冠病毒感染设计多表位疫苗的结构基础:计算机辅助疫苗设计与验证
JMIR Bioinform Biotechnol. 2020 Jun 19;1(1):e19371. doi: 10.2196/19371. eCollection 2020 Jan-Dec.
3
Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19.严重 COVID-19 患者炎症因子和淋巴细胞亚群特征。
J Med Virol. 2020 Nov;92(11):2600-2606. doi: 10.1002/jmv.26070. Epub 2020 Jun 9.
4
The Role of Antibody Testing for SARS-CoV-2: Is There One?新冠病毒抗体检测的作用:有这样一种作用吗?
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.00797-20.

血清 2019-nCoV IgM/IgG 动态变化与患者出院后 6 个月内免疫力的关系。

Relationship between the dynamic changes of serum 2019-nCoV IgM/IgG and patient immunity after 6 month hospital discharge.

机构信息

Department of Novel Coronavirus Pneumonia Rehabilitation Clinic, Hubei University of Chinese Medicine Affiliated Hubei Hospital of Chinese Medicine, 856 Hao, Luoyu Road, Hongshan, Wuhan, 430070, People's Republic of China.

出版信息

Inflamm Res. 2021 Feb;70(2):241-247. doi: 10.1007/s00011-020-01429-8. Epub 2021 Jan 1.

DOI:10.1007/s00011-020-01429-8
PMID:33385239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7775635/
Abstract

OBJECTIVES

To investigate the relationship between the dynamic changes of serum 2019-nCoV IgM/IgG and immunity alteration for patients after 6-month hospital discharge.

METHODS

One IgM(+) and IgG(-), 32 IgM(+) and IgG(+), 38 IgM(-) and IgG(+), and 40 IgM(-) and IgG(-) patients were included. Demographic data were collected. IgM and IgG antibodies, hypersensitive C-reactive protein (hs-CRP), interleukin-6 (IL-6) and lymphocyte subsets in serum were determined at weeks 0, 2 and 4.

RESULTS

The hs-CRP and IL-6 levels of all patients were within the normal ranges. The number of patients with all lymphocyte subset testing items within normal ranges was 12/110 (10.9%) at week 0, 15/110 (13.6%) at week 2 and 18/110 (16.4%) at week 4. The percentages of CD8 + cells, NK cells and B lymphocytes in the IgM(+) and IgG(+) group were quite different from those in the IgM(-) and IgG(+) group and the IgM(-) and IgG(-) group, with much higher percentages of CD8 + cells and much lower percentages of NK cells and B lymphocytes at weeks 0, 2 and 4. Twelve IgM(+) patients in the IgM(+) and IgG(+) group converted to IgM(-), and the percentages of NK cells and B lymphocytes in these patients were significantly increased at week 4.

CONCLUSIONS

The changes of serum IgM and IgG are closely related to immunity in patients in the recovery stage. However, immunity does not recover when the patients test negative for these antibodies.

摘要

目的

探讨血清 2019 型新型冠状病毒(2019-nCoV)IgM/IgG 动态变化与患者出院后 6 个月免疫改变的关系。

方法

纳入 1 例 IgM(+)、IgG(-),32 例 IgM(+)、IgG(+),38 例 IgM(-)、IgG(+)和 40 例 IgM(-)、IgG(-)患者。收集患者的人口学资料。于 0、2、4 周检测血清 IgM、IgG 抗体、超敏 C 反应蛋白(hs-CRP)、白细胞介素 6(IL-6)和淋巴细胞亚群。

结果

所有患者 hs-CRP 和 IL-6 水平均在正常范围内。在 0 周、2 周和 4 周时,所有淋巴细胞亚群检测项目均在正常范围内的患者分别为 12/110(10.9%)、15/110(13.6%)和 18/110(16.4%)。在 IgM(+)和 IgG(+)组中,CD8+细胞、NK 细胞和 B 淋巴细胞的百分比与 IgM(-)和 IgG(+)组以及 IgM(-)和 IgG(-)组有很大不同,在 0、2 和 4 周时,CD8+细胞的百分比明显更高,NK 细胞和 B 淋巴细胞的百分比明显更低。在 IgM(+)和 IgG(+)组中,12 例 IgM(+)患者转为 IgM(-),这些患者在第 4 周时 NK 细胞和 B 淋巴细胞的百分比显著增加。

结论

血清 IgM 和 IgG 的变化与恢复期患者的免疫密切相关,但当患者这些抗体检测阴性时,免疫并未恢复。